Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nath Bio-Genes (India) Ltd. ( (IN:NATHBIOGEN) ) has provided an update.
Nath Bio-Genes (India) Ltd. has announced that its trading window for dealing in the company’s securities will be closed from 1 January 2026 until 48 hours after the announcement of its unaudited financial results for the quarter and nine months ended 31 December 2025, in line with SEBI’s Prohibition of Insider Trading Regulations and its internal code of conduct. The company will separately notify the date of the board meeting for approving these unaudited results, a procedural move aimed at preventing insider trading and ensuring fair disclosure practices for investors and other market participants.
More about Nath Bio-Genes (India) Ltd.
Nath Bio-Genes (India) Ltd. operates in the agricultural and biotechnology sector, focusing on the development, production and marketing of seeds and related agri-inputs for the Indian market, with its securities listed on both BSE and NSE under the codes 537291 and NATHBIOGEN respectively.
Average Trading Volume: 1,863
Technical Sentiment Signal: Sell
Current Market Cap: 3.06B INR
For an in-depth examination of NATHBIOGEN stock, go to TipRanks’ Overview page.